Editorial: COP22 – Marrakech 2016: Is the implementation of the Kyoto Protocol dead?

No Abstract

Editorial

South Africa and national TB control: Are we making progress

Glucose Control: non-insulin therapies

This chapter summarises information for each of the non-insulin drug classes that are used for blood glucose control. Each summary is accompanied by a table of recommendations to guide the clinical use of these medications. For the sake of completeness, and for those that are interested, we have included a more detailed review of each drug as an appendix to each summary. These can be found in the Appendix section of the guidelines. The treatment recommendations for each drug have been incorporated into the treatment algorithm in Chapter 11. The following abbreviations are used in this chapter:DPP-4: dipeptidyl peptidase-4GLP-1: glucagon-like peptide-1SGLT2- sodium-glucose linked transporter-

Editorial: Nanotechnology and Health Care: What are the opportunities and possible risks?

No Abstrac

Editorial: Mental health and society’s perceptions

No Abstrac

Editorial

Cell phone use and ill health: Is there a definite relationship

Editorial: Listeriosis outbreak in South Africa: Are we winning the battle?

No Abstrac

Editorial: The health of our educators and HIV/AIDS

No Abstrac

Chapter 10: Glucose control: insulin therapy

The Society for Endocrinology, Metabolism and Diabetes of South Africa Type 2 Diabetes Guidelines Expert Committee.Chapter 10. Glucose control: insulin therapy in 2017 SEMDSA Guideline for the Management of Type 2 Diabetes Guideline Committee. JEMDSA 2017; 21(1 (Supplement 1): S49-50

Editorial: Publishing in predatory journals: Time for reflections

No Abstrac